This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waxman, D. J. Articles by Lapenson, D. P. Search for Related Content PubMed PubMed Citation Articles by Waxman, D. J. Articles by Lapenson, D. P.

Gene-specific Oligonucleotide Probes for , µ, , and Microsomal Rat Glutathione S-transferases: Analysis of Liver Transferase Expression and Its Modulation by Hepatic Enzyme Inducers and Platinum Anticancer Drugs¹

Department of Biological Chemistry and Molecular Pharmacology, and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115

Glutathione S-transferases (GSTs) play an important role in the detoxification of diverse electrophilic chemicals, including anticancer drugs. Gene-specific oligonucleotide probes were developed to monitor the expression of individual GST mRNAs in livers of adult male rats treated with drugs and other chemical modulators of GST expression. Northern blot analysis of total liver RNA using probes specific for individual GSTs belonging to classes (GSTs Ya1, Ya2, Yc), µ (GSTs Yb1, Yb2, Yb3), (GST Yp), and GST_ms demonstrated the expression in liver of all but Yp mRNA. Kidney GST expression was at least as high as that in liver for GSTs Ya1, Yc, and Yp, while it was substantially lower but still detectable for GSTs Ya2, Yb2, and GST_ms. Several of the liver GST class mRNAs, in particular Ya2, were inducible by pretreatment of rats with phenobarbital or isosafrole. In contrast, dexamethasone preferentially induced Yb1, Yb2, and Ya2, while two other inducers of liver drug metabolism, isoniazid and clofibrate, were less effective with respect to GST induction. GST_ms mRNA was induced to a small extent or not at all by the agents tested. Treatment of adult male rats with the anticancer drug cisplatin increased liver expression of GST Yc mRNA and suppressed Ya1 mRNA levels with little or no major effect on several other GST mRNAs. Western blot analysis of liver cytosols prepared from the cisplatin-treated rats revealed corresponding changes in GST Yc and Ya protein levels. Comparable changes in liver GST Ya1 and Yc expression were effected by the cisplatin analogue iproplatin but not by carboplatin or transplatin. This pattern of response to these platinum drugs is comparable to that seen with respect to platinum drug-induced gonadal toxicity and modulation of liver cytochrome P450 expression, suggesting a common mechanistic basis for these diverse effects of platinum anticancer drugs on hepatic enzymes of drug metabolism. Together, these studies demonstrate the utility of oligonucleotide probes for phenotyping liver tissue for the expression of GST enzymes that can contribute to anticancer drug metabolism and resistance. They also raise the possibility of drug-drug interactions involving cisplatin and alkylating agent anticancer drugs that can be metabolized in liver by -class GSTs.

¹ Supported by Grant CH-487 from the American Cancer Society.

² To whom requests for reprints should be addressed, at Dana-Farber Cancer Institute, Room JF-525, 44 Binney Street, Boston, MA 02115.

³ Present address: The Wellcome Research Laboratories, Burroughs Wellcome Co., Research Triangle Park, NC 27709.

Received 6/ 4/92. Accepted 8/10/92.

This article has been cited by other articles:

				K. C. Falkner, J. A. Pinaire, G.-H. Xiao, T. E. Geoghegan, and R. A. Prough Regulation of the Rat Glutathione S-Transferase A2 Gene by Glucocorticoids: Involvement of Both the Glucocorticoid and Pregnane X Receptors Mol. Pharmacol., September 1, 2001; 60(3): 611 - 619. [Abstract] [Full Text] [PDF]

				M. J. Kelner, R. D. Bagnell, M. A. Montoya, L. A. Estes, L. Forsberg, and R. Morgenstern Structural Organization of the Microsomal Glutathione S-Transferase Gene (MGST1) on Chromosome 12p13.1-13.2. IDENTIFICATION OF THE CORRECT PROMOTER REGION AND DEMONSTRATION OF TRANSCRIPTIONAL REGULATION IN RESPONSE TO OXIDATIVE STRESS J. Biol. Chem., April 21, 2000; 275(17): 13000 - 13006. [Abstract] [Full Text] [PDF]

				J. W. Lohr, G. R. Willsky, and M. A. Acara Renal Drug Metabolism Pharmacol. Rev., March 1, 1998; 50(1): 107 - 142. [Abstract] [Full Text] [PDF]

				R. Yuan, M. Sumi, and L. Z. Benet J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1499 - 1505. [Abstract]